Thierry Bernard

Thierry Bernard is the Chief Executive Officer of QIAGEN, a position he has held since March 2020.12 He joined QIAGEN in February 2015 as Head of the Molecular Diagnostics business area and became a member of the Managing Board in 2021.2

Career Highlights

• QIAGEN: CEO (October 2019 - Present)1
• bioMérieux SA: Held various roles over 15 years, including Corporate Vice President of Global Commercial Operations, Investor Relations, and the Greater China Region2
• ERAI: CEO (September 1990 - June 1997)1

Education

• Harvard Business School: Advanced Management Program (2009)1
• The London School of Economics and Political Science (LSE) (1987 - 1988)1
• College of Europe (1985 - 1986)1
• Sciences Po (1983 - 1985)1

Board Positions

• Chair of the AdvaMedDx Board of Directors (appointed March 2023)2
• Board Member of Neogen Corporation (NASDAQ: NEOG) (joined in 2024)2
• Board Member for several other companies, including First Light BioSciences and Huttopia & Cie1

Languages

Thierry Bernard is proficient in multiple languages:

• French and English: Native or bilingual proficiency
• Spanish: Native or bilingual proficiency
• German: Elementary proficiency1

Thierry Bernard has been recognized for his leadership in transforming QIAGEN and his expertise in molecular diagnostics.34 He is known for emphasizing the importance of humility, empathy, and surrounding oneself with diverse talents in leadership.5